Beijing Chunlizhengda Medical Instruments Co., Ltd. (688236.SS)

CNY 13.6

(-1.16%)

Annual Income Statements

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue 1.19 Billion 1.2 Billion 1.1 Billion 937.68 Million 855.32 Million 497.92 Million
Cost of Revenue 355.25 Million 288.07 Million 253.59 Million 256.93 Million 261.86 Million 180 Million
Gross Profit 842.41 Million 913.52 Million 854.54 Million 680.75 Million 593.45 Million 317.92 Million
Operating Expenses 549.2 Million 581.19 Million 469.3 Million 345.91 Million 309.67 Million 201.14 Million
Selling, General and Administrative Expenses 432.02 Million 299.83 Million 352.73 Million 255.21 Million 233.17 Million 150.12 Million
Research and Development Expenses 157.44 Million 162.34 Million 104.84 Million 72.6 Million 57.74 Million 35.45 Million
Other Expenses -40.26 Million 119.01 Million 11.72 Million 18.1 Million 18.75 Million -150.4 Thousand
Cost and Expenses 902.54 Million 869.26 Million 722.9 Million 602.85 Million 571.54 Million 381.14 Million
Operating Income 305.97 Million 328.9 Million 367.59 Million 330.09 Million 298.57 Million 116.77 Million
Interest Expense 364.86 Thousand 16.2 Million 256.55 Thousand 141.59 Thousand 4.89 Million 96.04 Thousand
Income Tax Expense 28.08 Million 29.16 Million 45.01 Million 46.47 Million 36.23 Million 13.8 Million
Earnings before Tax 305.9 Million 336.87 Million 367.37 Million 329.84 Million 273 Million 119.44 Million
Net Income 277.82 Million 307.71 Million 322.36 Million 283.37 Million 236.76 Million 105.64 Million
Earnings Per Share Basic 0.72 0.80 0.84 0.82 0.68 0.31
Earnings Per Share Diluted 0.72 0.80 0.84 0.82 0.68 0.31
Weighted Average Shares Outstanding 385.86 Million 383.56 Million 384.28 Million 345.57 Million 348.17 Million 345.85 Million
Weighted Average Shares Outstanding (Diluted) 385.86 Million 383.56 Million 384.28 Million 345.57 Million 348.17 Million 345.85 Million
Gross Margin 0.70 0.76 0.77 0.73 0.69 0.64
EBIT Margin 0.28 0.32 0.39 0.38 0.36 0.26
Profit Margin 0.23 0.26 0.29 0.30 0.28 0.21
EBITDA 340.92 Million 367.29 Million 386.16 Million 345.15 Million 285.14 Million 124.19 Million
Earnings Before Tax Margin 0.26 0.27 0.33 0.35 0.35 0.23

Income Statement Charts